Step by Stepa HemeOncBuddy patient portal

Cabazitaxel

Illustration: Cabazitaxel

Say it: ka-BAZ-ih-TAX-el · Brand names: Jevtana

Cabazitaxel is a chemotherapy medicine that stops prostate cancer cells from dividing.

What it is

Cells need tiny inner tubes to split into two new cells. Cabazitaxel locks these tubes in place so the cell cannot divide. It can still work after a similar medicine, docetaxel, has stopped working.

Often used for

How you get it

Cabazitaxel is given through a vein (IV) in a clinic. The infusion takes about 1 hour. It is usually given once every 3 weeks, along with a steroid pill called prednisone. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Side effect guides

Sources

Quick answers

What is Cabazitaxel?
Cabazitaxel is a chemotherapy medicine that stops prostate cancer cells from dividing. Brand names: Jevtana.
What is Cabazitaxel used for?
prostate cancer that has spread and has grown after treatment with docetaxel.
How is Cabazitaxel given?
Cabazitaxel is given through a vein (IV) in a clinic. The infusion takes about 1 hour. It is usually given once every 3 weeks, along with a steroid pill called prednisone. Your schedule may be different.
What are the common side effects of Cabazitaxel?
Diarrhea. Feeling tired. Upset stomach or throwing up. Low blood counts. Changes in taste. Not feeling hungry. Numbness or tingling in the hands or feet.
When should I call my care team while taking Cabazitaxel?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Chills, a sore throat, a cough, or burning when you pee (signs of infection); Itching, rash, swelling of the face or lips, or trouble breathing during or soon after the infusion; Diarrhea that does not stop, or signs of dehydration like dizziness or very dark pee; Peeing much less than normal; Blood in your pee or stool, or black stool; Belly pain that is bad or does not go away.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.